Tag: Prescription Drugs
Avacopan Noninferior to Prednisone for ANCA-Associated Vasculitis
Avacopan noninferior to prednisone taper for remission at week 26, superior to prednisone taper for sustained remission at week 52
Enfortumab Vedotin Prolongs Survival in Advanced Urothelial Cancer
Overall survival longer compared with standard chemo for disease progression following platinum-based chemo and PD-1 or PD-L1 inhibitor
Certain Prostate Drugs Tied to Risk for Parkinson Disease
Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin
Cabozantinib Prolongs PFS in Papillary Renal Cell Carcinoma
Progression-free survival longer and response rate greater for cabozantinib versus sunitinib in phase 2 trial in adults with PRCC
ICI Need Not Be Withheld in Those With Autoimmune Disease
Objective response rates to anti-CTL4, anti-PD-1, combination similar for advanced melanoma patients with, without AID
Actionable Drug-Gene Interactions Common in U.K. Primary Care
Actionable drug-gene interactions identified in 19.1 to 21.1 percent of all new prescriptions for 56 drugs
Once-Weekly Semaglutide Promising for Weight Loss
Weekly semaglutide plus lifestyle intervention resulted in substantial, sustained, clinically relevant weight loss for overweight, obese
Tirbanibulin Superior to Placebo for Actinic Keratosis
Significantly more patients treated with tirbanibulin had complete clearance of lesions at day 57
Psychoactive Prescription Meds Use, Misuse High for Young People
20.9 and 34.7 percent of youth aged 12 to 17 years, 18 to 25 years using psychoactive prescription medications report misuse
Combination Monoclonal Antibody Treatment Authorized for COVID-19
EUA issued for combination of bamlanivimab and etesevimab in patients with mild-to-moderate COVID-19 at high risk for disease progression
